Translate Bio soars 30% after Sanofi agrees to buy the mRNA company for $3.2 billion
The deal represents a 56% premium to Translate Bio's volume-weighted average price per share over the past 60 days.
Full Article
Translate Bio soars 30% after Sanofi agrees to buy the mRNA company for $3.2 billion
Business Insider
0 shares
1 views
You might like
Related news coverage
-
US stocks finish in positive territory thanks to strong earnings
Proactive Investors
-
US stocks higher midday as strong earnings offset Delta variant concerns
Proactive Investors